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The statistics of ‘Cancer of the Female Lower Genital Tract’ are
that there are 19 chapters, contained within 308 pages, from 28
contributors or co-authors to cover cancers of the cervix, vagina
and vulva and certain rare tumours. The editors, Patricia J Eifel
and Charles Levenback, are respectively Professor of Radiation
Oncology and Associate Professor of Gynaecologic Oncology,
University of Texas, MD Anderson Cancer Center at Houston,
Texas, USA. Seven of their co-contributors are also based at the
MD Anderson, and all the others (except Evanthia Kostopoulou
of Thessaloniki, Greece) are North American. The book comes as
one of a large series ‘Atlas of Clinical Oncology’ of the American
Cancer Society and published by B.C. Decker, is accompanied by
a CD ROM, and is retailed at £95.00 in the UK.
The book has considerable North American orientation – the
demographics for vulval (vulvar) and vaginal cancer are for the
USA, although a more global picture is included for the cervix.
Some of the concepts or terminology are old – the term ‘dystro-
phy’ introduced by Professor Jeffcoate of Liverpool in the 1960s
does little to facilitate an understanding of the aetiology of vulval
cancer, and ‘smoking’ and ‘carcinogens from tobacco’ are barely
mentioned under vulval and cervical cancers. The chapter on mole-
cular biology gives a satisfactory review but its discussion of the
role of angiogenic factors in the transition from pre-invasive to
invasive lesions of the cervix and vulva is brief. It mentions the
work of the Cardiff group on vaccine therapy for cervical (and
vulval) neoplasia but misses opportunities to speculate how manip-
ulation of immune response, cycle cell activity (by reversing HPV
E6 proteins inhibitory effect on p53), potentiation of other tumour
suppressor genes and anti-angiogenesis might provide therapy in
the future.
I enjoyed the chapters on Anatomy and Diagnostic Imaging
because of the quality of the ﬁgures/illustrations. The computerised
tomography and magnetic resonance imaging, with appropriate
labelling, have been selected to demonstrate relevant oncological
challenges. The chapters on radiation therapy for invasive cervical,
vaginal and vulval cancer are also well illustrated. Discussion
includes concepts of technique, dose and dose rate, fractionation
and target volume and is valuable for the gynaecological oncologist
who is less familial with how radiation is prescribed. The chapter
on surgery for vulval cancer includes comments on excision
margins, alternatives to managing clitoral tumours, sentinel node
identiﬁcation and lymphatic mapping, and plastic surgical techni-
ques.
The ﬁnal chapter, appropriately, is on palliative care, and
describes salvage therapy, as well as the principles of palliation,
giving bad news and a table with ‘palliative pearls’ – the use of
tables throughout the text provides helpful summaries.
Does the CD ROM disc add anything extra? I was disappointed
because it provides a computerised version of the book; there are
no computer-assisted learning exercises or interactions. Some
may prefer scrolling through text on the screen but I would prefer
reading the book.
I do not regard this as a compulsory purchase for trainees in
gynaecological oncology but each training centre should buy a
copy.
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